Resection rate for patients with tissue confirmation of NSCLC (2004-2008:England) First seen in centre with thoracic surgery? Number With a tissue diagnosis.

Slides:



Advertisements
Similar presentations
LUNG CANCER LUNG CANCER Lung Cancer  What Is Lung Cancer?  Lung Cancer is a disease caused by the rapid growth and division of cells that make up the.
Advertisements

What do hospitals do for patient outcomes? 30 day mortality after heart attack Future of healthcare in Europe 13 May 2011.
Ravi Vohra West Midlands Research Collaborative Clinical Variation in Practice of Laparoscopic Cholecystectomy and Surgical Outcomes: a multi-centre, prospective,
Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.
How is place of death for cancer patients changing and what affects it? UKACR Conference September 28 th 2004 Elizabeth Davies Karen Linklater Ruth Jack.
A Survey of Quality of Life Following Surgery for Malignant Pleural Mesothelioma: Reflects the patients’ commitment to Learning about the Disease D A Raffle,
A Propensity-matched Study of Lobectomy Versus Segmentectomy for Radiologically Pure Solid Small-sized Non-small Cell Lung Cancer Terumoto Koike 1, Seijiro.
Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health.
Variations in Cancer Surgery Across the East Midlands and North Trent EMPHIN Forum (Apr 2010) Carolynn Gildea Trent Cancer Registry.
The Relationship of Surgeon and Hospital Volume with Long-Term Survival For Women with Breast Cancer Patrick J. Roohan New York State Department of Health.
The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
Surgeon Specialty and Operative Mortality With Lung Resection PP Goodney, FL Lucas, TS Stukel, JD Birkmeyer VA Outcomes Group, White River Junction, VT.
Black Patients Die Earlier after Surgery for Esophageal Cancer Andrea S. Wolf, MD, MPH, Emanuela Taioli MD, PhD, Marlene Camacho-Rivera, ScD, MPH, Andrew.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Healthcare Workforce and Regionalization of Services: Lung Cancer Resections Stephen C. Yang, M.D. Chief of Thoracic Surgery The Arthur B. and Patricia.
Stomach – UK July 2007.
LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust.
Cancer Information Framework Initial feedback on NWCN LUCADA submission 2006 data Wednesday 20 th February, 2008 Linda Roberts, Cancer Information Specialist,
Network Audit Patients with Confirmed Small Cell Lung Cancer Who Did Not Receive Chemotherapy Dr D N Leitch On Behalf of Lung Cancer NSSG NECN.
National Oesophago–Gastric Cancer Audit  This slide set is designed to ◦Summarise the main audit findings for presentation at local MDT meetings.
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
How clinicians use data to make an impact on clinical outcomes Andrew Brodbelt Consultant Neurosurgeon and Clinical Director of Neurosurgery, The Walton.
South West Public Health Observatory South West Regional Public Health Group Opportunities for future analysis by SWPHO Sean McPhail South West Public.
Midland Cancer Network 2012 Clinical Performance Conference.
Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly: A Population-Based Study in Ontario, Canada JOURNAL OF CLINICAL ONCOLOGY, VOLUME 30.
Uses of Cancer Data by RTPCT Cancer Chapter of the Public Health Annual Report 2003 Dr José M Ortega.
Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,
QUICK DESIGN GUIDE (--THIS SECTION DOES NOT PRINT--) This PowerPoint 2007 template produces a 36”x60” professional poster. You can use it to create your.
How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.
Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.
Cancer - What’s available from the LHO? David Hofman.
Cheshire and Merseyside Strategic Clinical Networks Local Issues and Challenges 22 nd May 2015.
Prostate cancer and socio-economic deprivation When PCTs are ranked according to their income score using the Indices of Multiple Deprivation (IMD)* there.
Oesophago–Gastric Cancer Audit
Treatment of Stage I and II Non-small Cell Lung Cancer
Brain imaging prior to lung cancer resection
How clinicians use data to make an impact on clinical outcomes
Oesophago–Gastric Cancer
National Oesophago–Gastric Cancer Audit 2015.
Curative treatment rates for patients diagnosed with
Prognosis of younger patients in non-small cell lung cancer
Oesophago–Gastric Cancer
Fig 3. Time trends for infant mortality rate and hazard ratio according to the deprivation quintiles. (A) Time trend for the infant mortality rate according.
Results Results Introduction Objectives Conclusions
National Lung Cancer Audit
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Segmented analysis of the lung cancer median pathway from referral to treatment: This work was carried out in partnership between the Transforming.
NHS England Service Specification for Thoracic Surgery (Adult)
Treatment of Stage I and II Non-small Cell Lung Cancer
Hannah Marder Cancer Manager UH Bristol
Results from the first National Lung Cancer Organisational Audit.
Treatment breakdown for hypopharynx cancers
Treatment of Stage I and II Non-small Cell Lung Cancer
Improved Lymph Node Staging in Early-Stage Lung Cancer in the National Cancer Database  Seth B. Krantz, MD, Waseem Lutfi, BS, Kristine Kuchta, MS, Chi-Hsiung.
Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer  Anthony W.
Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E
Patient characteristics associated with inpatient mortality within 1 year after hip fracture surgery (multivariable logistic regression model adjusted.
Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer  Raymond U.
P. Michael Grossman et al. JCIN 2009;2:
Variation in Hospital Adoption Rates of Video-Assisted Thoracoscopic Lobectomy for Lung Cancer and the Effect on Outcomes  Zaid M. Abdelsattar, MD, MS,
ES Lung Cancer Surgery for High Risk Patients
Christopher W. Seder, MD, Cameron D. Wright, MD, Andrew C
The Effects of Increased Provision of Thoracic Surgical Specialists on the Variation in Lung Cancer Resection Rate in England  Kelvin K.W. Lau, DPhil,
National data in surgery: LCCOP 2018(2016)
Surgical resection update
Yinin Hu, MD, Timothy L. McMurry, PhD, Kristen M. Wells, PhD, James M
Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study  Robert J. Cerfolio, MD, Ayesha.
Benjamin D. Kozower, MD, MPH, Shubin Sheng, PhD, Sean M
Presentation transcript:

Resection rate for patients with tissue confirmation of NSCLC ( :England) First seen in centre with thoracic surgery? Number With a tissue diagnosis of NSCLC Number who had surgical resection % having surgery Adjusted Odds Ratio for surgery* P value No25,2482,94712%1.00 Yes9,265 (27%) 1,53817%1.51 ( ) <0.001 *adjusted for sex, age, PS, stage, deprivation index and Charlson co-morbidity index

Resection rate by PCT * *Source: National Cancer Data Repository

N = 77,349 Mortality Hazard Ratios for Lung Cancer Patients in England related to resection rate by government office region

Mortality hazard ratios for resected patients; England by Government Regional Office N = 6,900

Mortality hazard ratios for resected patients; England by Government Regional Office N = 6,900 Implications: comparing the top quintile PCT with Lower 4: 5420 deaths ‘postponed’ by surgery 146 deaths related to higher resection rates

Kelvin Lau David Waller Sridhar Rathinam Michael Peake Glenfield Hospital, Leicester, UK UK National Lung Cancer Audit Programme The effects of investing in thoracic surgery on lung cancer resection rates

Lung cancer in UK is under treated

There is a wide variation in lung cancer surgery in England 5.2% – 10.1% 10.9% – 13.2% 13.6% – 14.5% 14.6% – 16.5% 16.9% – 31.8%

Hypothesis the variability in Resection Rate is determined by the provision of specialist thoracic surgery Method We correlated results of the NATIONAL LUNG CANCER AUDIT with manpower data for cardiothoracic surgery

National Lung Cancer Audit results 33 English Cancer Networks, comprising 174 Hospital Trusts 31 Trusts had Thoracic Surgery in house (Base Hospitals) 18 (58%) Trusts had less than 2 Pure Thoracic Surgeons 13 (42%) Trusts had 2 or more Pure Thoracic Surgeons In 2008, 15,774 cases of histologically confirmed NSCLC –18.4% cStage I and II –14.2% underwent resection

Resection rates are higher in centres who treat more cases R = p = 0.06

Resection rates are higher in base than in referring centres p < Resection Rate p < Across the UKWithin each Cancer Network

Resection rates are higher in centres with 2 or more specialist thoracic surgeons p = 0.02 Resection Rate

Resection rates are higher when surgeons attend preoperative MDTs p = 0.012

The increase in resection rate was greatest in those units who employed new thoracic surgeons p = % 66% Growth Resection Rate

Conclusion Lung cancer resection rates in UK can be increased by Increasing the number of specialist thoracic surgeons at preoperative MDTs in referring hospitals Increasing the number of specialist thoracic surgeons in operating centres Thereby increasing the individual caseload in any unit Individual Units must invest in more pure Thoracic Surgical appointments The number of specialist thoracic surgeons in training must be increased

Resection Rate - Leicester Surgical Numbers Resection Rate for confirmed NSCLC Resection Rate for all Lung Cancers * * * A Martin-Ucar et al. Lung Cancer. 2004; 46: (specialist thoracic surgeon appointed 1997)